AvKARE Recalls

63 recalls on record in the United States

drugs: 63
drugs Class II
2026-03-04

AvKARE recalls Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10)

Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

View recall details →

drugs Class II
2026-01-14

AvKARE recalls Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 1

Out of specification for dissolution.

View recall details →

drugs Class II
2025-10-15

AvKARE recalls Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.0

Failed Content Uniformity Specifications

View recall details →

drugs Class II
2025-09-17

AvKARE recalls chloroproMAZINE Hydrochloride Tablets, USP, 50 mg, 50 Tablet

Presence of a foreign substance.

View recall details →

drugs Class II
2025-09-17

AvKARE recalls chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Table

Presence of a foreign substance.

View recall details →

drugs Class III
2025-07-09

AvKARE recalls Pitavastatin Tablets, 1 mg, 90 Tablets per bottle, Rx Only,

Failed Impurity/Degradation Specifications

View recall details →

drugs Class III
2025-07-09

AvKARE recalls Pitavastatin Tablets, 2 mg, 90 Tablets per bottle, Rx Only,

Failed Impurity/Degradation Specifications

View recall details →

drugs Class II
2025-06-18

AvKARE recalls Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit D

Failed Dissolution Specifications

View recall details →

drugs Class II
2025-06-18

AvKARE recalls Celecoxib Capsules, 200 mg, 50 Capsules (5x10) Unit Dose per

Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsules

View recall details →

drugs Class II
2025-02-26

AvKARE recalls Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactu

Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)

View recall details →

drugs Class II
2025-02-19

AvKARE recalls Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dos

Out of Specification for Dissolution

View recall details →

drugs Class III
2025-01-08

AvKARE recalls Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moist

LABELING: LABEL MIX-UP

View recall details →

drugs Class II
2025-01-08

AvKARE recalls Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) U

Failed Dissolution Specifications

View recall details →

drugs Class III
2025-01-08

AvKARE recalls Polyvinyl Alcohol Ophthalmic Solution 1.4%, Moisturizing Lub

LABELING: LABEL MIX-UP

View recall details →

drugs Class II
2024-12-11

AvKARE recalls Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx Onl

Labeling: Label Mix-Up

View recall details →

drugs Class II
2024-12-11

AvKARE recalls Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufac

CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.

View recall details →

drugs Class II
2024-12-11

AvKARE recalls Cinacalcet Tablets, 90 mg, 30-count bottle, Rx only, Manufac

CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.

View recall details →

drugs Class II
2024-12-11

AvKARE recalls Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufac

CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.

View recall details →

drugs Class II
2024-12-11

AvKARE recalls Sunitinib Malate Capsules, 25 mg, 28-count bottles, Rx Only,

Labeling: Label Mix-Up

View recall details →

drugs Class I
2024-04-24

AvKARE recalls Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20

Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.

View recall details →

drugs Class II
2023-09-13

AVKARE LLC recalls Capsaicin Cream 0.025%, External Analgesic Cream, Penetratin

Product mix-up: Cartons labeled Capsaicin Cream 0.025% may contain tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste

View recall details →

drugs Class II
2023-09-13

AVKARE LLC recalls Sodium Fluoride 1.1%, SODIUM FLUORIDE Prescription Dental To

Cases of Sodium Fluoride 1.1% Prescription Dental Toothpaste may contain cartons labeled as Capsaicin Cream 0.025% but contain correctly labeled tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste

View recall details →

drugs Class III
2023-06-21

AVKARE LLC recalls Tranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

View recall details →

drugs Class II
2023-01-04

AVKARE LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Do

Failed impurities/degradation specifications: Out of specification for unknown impurities.

View recall details →

drugs Class III
2022-08-17

AVKARE Inc. recalls Lamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only

Labeling: Label Error on Declared Strength

View recall details →

drugs Class III
2021-06-23

AVKARE Inc. recalls Phytonadione Tablets 5 mg, Rx Only, 30 Tablets (3x10) Unit D

Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.

View recall details →

drugs Class I
2020-12-23

AVKARE Inc. recalls TraZODONE Hydrochloride Tablets USP 100 mg, Rx Only, 1000-co

Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.

View recall details →

drugs Class II
2020-12-23

AVKARE Inc. recalls Sildenafil Tablets USP 100 mg, Rx Only, 100-count Bottle, Ma

Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.

View recall details →

drugs Class II
2020-11-18

AVKARE Inc. recalls Mesalamine Delayed-Release Tablets, USP 1.2 gram (Once-Daily

Failed Dissolution Specifications

View recall details →

drugs Class II
2020-06-24

AVKARE Inc. recalls Metformin Hydrochloride Extended-Release Tablets, USP 500 mg

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

View recall details →

Showing 30 of 63 recalls. See all →